Yazar: Douglas Bowman

Steven Haney is a Senior Research Advisor and Group Leader at Eli Lilly and Company. He edited the book High Content Screening: Science, Techniques, and Applications (Wiley, 2008). Douglas Bowman is an Associate Scientific Fellow at Takeda Pharmaceuticals. Arijit Chakravarty is the Director of Modeling and Simulation (DMPK) at Takeda Pharmaceuticals. Anthony Davies is Center Director, Translational Cell Imaging, Queensland University Of Technology, Queensland, Australia. Caroline Shamu is the Director of the ICCB-Longwood Screening Facility at Harvard Medical School.